您的当前位置:首页 > 行业数据 > 图14、中国人用狂苗各细胞类型占批签发量比
图片属性
图片格式:PNG 图片大小:81KB 图片尺寸:1627*1076
同报告图片
 / 4
图14、中国人用狂苗各细胞类型占批签发量比_第1页
fCB2ZXJv57uG6IOeIHwg5Lq65LqM5YCN5L2T57uG6IOeIHwg5Zyw6byg6IK+57uG6IOeIHwKfC0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwKfCA4OC44MCUgICAgfCA1LjgwJSAgICAgICAgfCA1LjQwJSAgICAgIHwKCui1hOaWmeadpea6kO+8muaymeWIqeaWh+OAgea5mOi0ouivgeWIuOeglOeptuaJgO+8iDIwMjHlubTmlbDmja7vvIk=
图14、中国人用狂苗各细胞类型占批签发量比_第2页
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
图14、中国人用狂苗各细胞类型占批签发量比_第3页
图14、中国人用狂苗各细胞类型占批签发量比_第4页
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
图14、中国人用狂苗各细胞类型占批签发量比_第5页
所属报告: 康华生物-公司研究报告-狂苗先发优势明显诺如疫苗带来业绩新增长极-250114(31页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠